1. Home
  2. BKSY vs DRUG Comparison

BKSY vs DRUG Comparison

Compare BKSY & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackSky Technology Inc.

BKSY

BlackSky Technology Inc.

HOLD

Current Price

$21.33

Market Cap

726.7M

Sector

Technology

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$81.65

Market Cap

856.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKSY
DRUG
Founded
2013
2019
Country
United States
United States
Employees
340
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
726.7M
856.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BKSY
DRUG
Price
$21.33
$81.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$28.50
$114.00
AVG Volume (30 Days)
1.3M
83.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$35.67
N/A
Revenue Next Year
$33.51
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.15
$23.18
52 Week High
$33.20
$123.75

Technical Indicators

Market Signals
Indicator
BKSY
DRUG
Relative Strength Index (RSI) 49.62 50.32
Support Level $18.88 $77.80
Resistance Level $22.48 $97.75
Average True Range (ATR) 2.07 5.70
MACD -0.11 0.43
Stochastic Oscillator 55.81 53.95

Price Performance

Historical Comparison
BKSY
DRUG

About BKSY BlackSky Technology Inc.

BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: